Leor Sapir: The Questions the New York Times Refused to Ask (#27)
7 August 2025
With Leor Sapir
institutions
When the New York Times devoted six episodes to investigating youth gender medicine, it somehow avoided the most basic question: what is gender identity? Leor Sapir, a Manhattan Institute fellow who has built a reputation scrutinising the evidence base for paediatric transition, dissects how a flagship media institution shaped public understanding while refusing to interrogate its own assumptions. The episode exposes the gap between the appearance of rigorous journalism and the reality of ideological constraint — and what that gap costs when children's bodies are at stake.
Leor Sapir is a fellow at the Manhattan Institute whose work focuses on the evidence base — or lack of one — underpinning paediatric gender transition policy. He has spent years tracking how research gets produced, cited, and misrepresented within a field that moves faster than the science it claims to apply. That background makes him a particularly precise guide to how the New York Times spent two years investigating youth transition and managed, across six podcast episodes, to avoid every foundational question. The series in question is "The Protocol," the Times' attempt to reckon with a controversy that has quietly reshaped paediatric medicine across the English-speaking world. Sapir's critique is not that the journalism was careless — it is that it was strategic. The podcast positioned what he describes as unscientific psychosocial assessment as the sensible, evidence-based middle ground, lending the imprimatur of the world's most-read newspaper to an approach that cannot actually define what it is treating. His central observation cuts through layers of procedural language: you cannot have a rigorous protocol for a condition you cannot define without resorting to circular reasoning. The admission that throws this into sharpest relief came from Sapir's own interview with Laura Edwards-Leeper, a clinical psychologist frequently cited as a voice for caution within the field. During that conversation, Edwards-Leeper acknowledged that gender identity is grounded in stereotypes — a concession with enormous implications that, according to Sapir, the Times chose not to pursue. It is the kind of admission that would ordinarily anchor an investigative series. The fact that it was left to surface elsewhere reveals something important about the limits the newspaper placed on its own inquiry. The podcast's handling of human testimony was equally telling. Detransitioners — people who transitioned and later came to regret it — received approximately thirty seconds of acknowledgment. Jamie Reed, the whistleblower whose testimony about a major gender clinic helped shift the policy landscape in the United States, was not treated as a source to be listened to but as a figure to be scrutinised and questioned. The asymmetry is not incidental. It reflects a prior judgement about whose experience counts as evidence and whose is an inconvenience to be managed. Behind the media critique runs a structural question about where accountability will come from now. Sapir sketches a choice that medical institutions are beginning to face: allow leaders to redirect blame onto WPATH, the international body that set many of the guidelines now being revised or abandoned across Europe, or face a different kind of reckoning through government investigations. Neither path is comfortable, and the choice of framing will determine what gets examined and what gets quietly buried. What the episode ultimately demonstrates is how a trusted institution can invest considerable resources in a difficult subject and still leave the hardest questions untouched. The New York Times did not suppress the story of youth gender medicine — it covered it in a way that made the story seem settled. For an ideology that depends on avoiding definitional scrutiny, that kind of coverage may be more protective than silence.
